Skip to main content
. 2022 Nov 1;26:336. doi: 10.1186/s13054-022-04216-5

Table 2.

Comparison between patients whose family surrogate did or did not participate in 6–24 months bereavement surveys (N = 353)

Variable, n (%) Participated (n = 303) Declined (n = 50) p
Gender .455
Male 192 (63.4%) 35 (70.0%)
Female 111 (36.6%) 15 (30.0%)
Diagnosis .600
Cancer 149 (49.2%) 31 (62.0%)
Chest 22 (7.3%) 2 (4.0%)
Cardiovascular 14 (4.6%) 3 (6.0%)
Digestive 11 (3.6%) 1 (2.0%)
Kidney 16 (5.3%) 2 (4.0%)
Other 91 (30.0%) 11 (22.0%)
Acute symptoms/problems at admission .344
Respiratory failure/distress 157 (51.8%) 26 (52.0%)
Infection 85 (28.1%) 14 (28.0%)
Shock 24 (7.9%) 1 (2.0%)
Bleeding 10 (3.3%) 2 (4.0%)
Cardiac arrest 11 (3.6%) 1 (2.0%)
Others 16 (5.3%) 6 (12.0%)
Comorbidity .625
Yes 260 (85.8%) 41 (82.0%)
No 43 (14.2%) 9 (18.0%)
Variable, mean (SD)
Age (years) 66.72 (14.37) 65.96 (10.86) .666
APACHEa 28.30 (5.37) 28.68 (5.73) .663
SOFAa 12.38 (4.04) 12.24 (4.07) .823
Length of ICU stay (days) 21.06 (15.37) 21.58 (13.19) .800
Time from ICU admission to enrollment (days) 14.78 (12.75) 14.52 (8.36) .855
Time from enrollment to death (days) 7.28 (8.49) 8.06 (9.65) .593

aMeasured at enrollment